Biomarkers: Technological and Commercial Outlook 2011-2021 - discovering the pharma and diagnostics

Bharat Book Bureau introduces a new report on " Pharma and diagnostics which gives the market trends of Biomarkers: Technological and Commercial Outlook 2011-2021 - discovering the pharma and diagnostics opportunities ".
By: Bharatbook
 
Aug. 20, 2011 - PRLog -- What are the commercial prospects for biomarkers in pharma and diagnostics? Our new report shows you commercial opportunities for biomarkers, predicting future trends. Through our research and analysis we aim to save you time and help in your decisions.

You will find revenue forecasts to 2021 at overall world, submarket and national levels. What technologies and applications will increase the use of biomarkers? What effects will changes and regulations have? You will find predictions and opportunities.

In our study you will find discussions of genomic and proteomic approaches to biomarker discovery, including metabolomics and microarray platforms. You will see how biomarker technologies are changing pharma and diagnostics.

You will discover commercial activities of Affymetrix, Agilent, Stemina Biomarker Discovery, Crown Bioscience and other biomarker specialists. We also discuss the activities of Pfizer, J&J, GSK, Sanofi, Novartis, AstraZeneca, Roche and other pharma leaders.

Our report shows you revenue predictions for biomarkers in oncology, cardiovascular and central nervous system applications. You will also see forecast revenues for genomics, proteomics and bioinformatics. We show you trends to watch.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Original analysis with revenues, growth rates, market shares, opinion and discussions

You will find revenue forecasts, growth rates, market shares, a SWOT/STEP review, opinions from our survey and discussions of technologies and companies. We provide 76 tables and charts and three research interviews (shown in the accompanying lists).

Biomarkers: Technological and Commercial Outlook 2011-2021 shows you opportunities, challenges and revenue forecasts

Our report gives you the following advantages:
• You will discover revenue forecasts to 2021 for the world biomarkers market and its main components, seeing where the highest revenue growth will occur
• You will appraise the future of biomarkers research from scientific, technological and commercial perspectives, seeing R&D trends
• You will receive revenue forecasts for the leading therapeutic areas for biomarker technologies - oncology, cardiovascular diseases and CNS disorders - to 2021
• You will see forecast revenues for genomics, proteomics and bioinformatics to 2021
• You will find discussions of biomarker research and assess the importance of that work for patient stratification and targeted therapies
• You will receive revenue forecasts for the leading national markets for biomarkers to 2021 - the US, the UK, Canada, Germany, France, Spain, Italy, Japan, China and India - seeing growth prospects
• You will investigate activities of leading companies developing biomarkers
• You will assess the activities of leading pharmaceutical companies using biomarkers, reviewing partnerships with industry and academia
• You will investigate competition and opportunities influencing the industry and market from 2011 onwards
• You will see what will stimulate and restrain the industry and market from 2011
• You will analyse opportunities and challenges for established companies and those seeking to commercialise biomarkers
• You will view opinions from three interviews with authorities on biomarkers.

That mix of quantitative and qualitative analysis sets our report apart. We tackle crucial questions, helping you to stay ahead. You will discover trends in biomarkers through predictions found only in our work.

Order our report now to gain industry and market analysis for biomarkers

Our report is for essential for anyone interested in biomarkers, drug development, medical diagnostics and personalised medicine. You will find predictions and answers. Don't miss out - please order our report now.

For more information kindly visit :
http://www.bharatbook.com/detail.asp?id=203598&rt=Biomark...

Related Reports
The 2011-2016 World Outlook for Pharmaceutical Preparations for Veterinary Use Excluding Diagnostics

The 2011-2016 World Outlook for Pharmaceutical Preparations for Human Use Affecting Parasitic and Infectious Diseases Excluding Diagnostics
Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/BharatBook

# # #

Bharatbook.com is the leading business information aggregator and an easy access to more than 150,000 market reports.
End
Source:Bharatbook
Email:***@bharatbook.com
Posted By:***@bharatbook.com Email Verified
Zip:400614
Tags:Research, Diagnostics, Healthcare, Market Report, Report, Clinical Trial
Industry:Health
Location:Navi Mumbai - Maharashtra - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Bharatbook.com News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share